NOTCH1 and T-cell leukemia: To analyze the role of Notch signaling in the expression of eIF6, three T-Cell leukemia-derived cell lines (Jurkat, SKW3 and MOLT-3) known to carry gain-of-function mutations in Notch-1 [21] were treated with γ-secretase inhibitors (GSI).